KDM6A and chronic kidney disease: Cognizant that advances in chronic kidney disease (CKD) therapeutics have shifted the spotlight towards damage of kidney tubules as being the primary force in CKD progression (Gilbert, 2017; Heerspink et al., 2020; Liu et al., 2018), we explored the expression and actions of KDM6A in tubule epithelial cells.